Teo (Healthcare Technology Systems)

• ·Provider of telemedicine services intended to support ophthalmologists in the opening and management of secondary practices in telemedicine.
• ·Teo (Healthcare Technology Systems) is valued at approximately $47.8M as of Oct 2026 (last reported valuation).
• ·It has raised $14.9M; the latest was PE Growth/Expansion in Apr 2026.
• ·Notable investors include Ring Capital, Holnest, Bertrand Quenot, Bouscas Med, Club Holnest — 8 tracked in total.
• ·Status: Privately Held (backing).

Provider of telemedicine services intended to support ophthalmologists in the opening and management of secondary practices in telemedicine. The company deploys support teams to assist the doctor's secondary office in terms of administration and logistics, also perform visual assessments of the patients and transmit their files to the ophthalmologist, which is reviewed by the doctor and the updated prescription is sent back to the patient via post, enabling ophthalmologist to refocus on core business, diagnosis and cultivate the skills of orthoptists as part of an optimal care path for the patient.

Sector

Healthcare

HQ

Bordeaux, France

Founded

2018

Employees

77

Website

teo-med.fr/

Ownership

Privately Held (backing)